Scopio Labs Gets FDA Clearance for Digital Bone Marrow Aspirate Application
Scopio Labs received De Novo clearance from the FDA for its Full-Field Bone Marrow Aspirate (FF-BMA) Application.
Scopio Labs received De Novo clearance from the FDA for its Full-Field Bone Marrow Aspirate (FF-BMA) Application.
A study found an active surveillance blood test for prostate cancer could predict whether a patient had indolent or aggressive disease.
Bio-Rad and Oncocyte are collaborating on transplant monitoring products using Bio-Rad’s Droplet Digital PCR instruments and reagents.
Verichem Laboratories upgraded its web-based, CLIA-compliant data reduction and test reporting software program.
Agilent Technologies announced that its GenetiSure Dx Postnatal Assay received European IVDR Class C Certification.